Key Resources


ASGE Guidelines

ASGE evidence-based guidelines provide clinicians with recommendations for the evaluation, diagnosis, and management of patients undergoing endoscopic procedures of the digestive tract. Guidelines are not a substitute for physicians’ opinion on individual patients. Final decision on an intervention should always be based on local expertise and patient preferences.

All recommendations follow a rigorous process based on a systematic review of medical literature as outlined by the National Academy of Medicine (formerly Institute of Medicine) standards for guideline development.

Whenever possible, guidelines are based on the GRADE (Grading of Recommendation Assessment, Development and Evaluation) methodology.

Panels consist of content experts, stakeholders from other specialties, patient representatives, and members of the ASGE Standards of Practice (SOP) Committee.

Each recommendation is based on consideration of the best medical literature, the balance between risks and benefits, cost-effectiveness, patients’ values, and equity.

Panel members provide ongoing conflict of interest (COI) disclosures, including intellectual conflicts of interest, throughout the development and publication of all guidelines in accordance with the ASGE Policy for Managing Declared Conflicts of Interests.

ASGE strives to provide clinically relevant and practical recommendations, which can help standardize patient care and improve outcomes.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
GRADE Guidelines

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Upper GI

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Lower GI

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Biliary and Pancreatic Endoscopy

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Adverse Events

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Privileging and Credentialing

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
GI Endoscopy Unit Operations

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Screening and Surveillance in Premalignant Conditions

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Procedural Management in Endoscopy

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Miscellaneous

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies
Guidelines in Spanish

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies

In Progress Guidelines

ASGE Guideline on the Role of Endoscopy in the Management of Malignant Hilar Obstruction

Early 2021

ASGE Guideline on the Management of Cholangitis

Early 2021

ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility

Estimated 2021

ASGE Guideline on the Role of Endoscopic Submucosal Dissection in the Management of Esophageal and Gastric Mucosal Neoplasia

Estimated 2021

Quality in Endoscopy

Quality documents define the indicators of high-quality endoscopy and how to measure it. ASGE quality indicators are based on a rigorous review process which results in valid metrics for evaluating GI endoscopic procedures. 

Quality in Endoscopy

ASGE Position Statement: endoscopic bariatric therapies in clinical practice

Nov 14, 2016, 20:26 PM
The American Society for Gastrointestinal Endoscopy (ASGE), as well as a number of federal agencies and medical societies, recognizes obesity as a disease requiring primary therapy.1 In 2011, the ASGE and the American Society for Metabolic and Bariatric Surgery (ASMBS) jointly published a white paper with the intent of providing a pathway for bringing endoscopic bariatric therapy (EBT) to clinical practice and Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for safety and efficacy.2 As multiple EBTs are on the verge of being approved for clinical use, this position statement addresses the ASGE position on the role of the endoscopist in the primary treatment and bridge treatment of obesity with EBT.
Shelby Sullivan, MD , Nitin Kumar, MD , Steven A. Edmundowicz, MD, FASGE , Barham K. Abu Dayyeh , Sreenivasa S. Jonnalagadda, MD, FASGE , Michael Larsen, MD , Christopher C. Thompson, MD, MSc, FASGE
Title : ASGE Position Statement: endoscopic bariatric therapies in clinical practice
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.06.038
Volume : Gastrointest Endosc 2015;82:767–772
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/position_statement_endoscopic_bariatric_therapies.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Aug 14, 2015, 09:08 AM
File size :
Number :
ExternalPK : 18329
Categories :
  • Bariatric Endoscopy
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
  • Privileging & Credentialing
  • Stomach
Tags :
Position_statement_endoscopic_bariatric_therapies

Technology Assessments

Technology evaluations provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Evaluations are based on a literature review and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided.

Technology Assessments
80_logo